MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
Cardinal Health stock hit a new all-time high after mixed earnings, with analyst price target hikes, gene therapy logistics wins and a 29-year dividend growth streak supporting the uptrend.
Jumia Technologies (NYSE:JMIA) reported second-quarter 2026 results marked by higher order volumes, expanding gross profit and a narrower adjusted EBITDA loss, while supply disruptions in electronics, fuel surcharges and weaker purchasing power in Ivory Coast weighed on GMV growth.
Chief Executive
Korea Electric Power (NYSE:KEP) reported preliminary consolidated operating income of KRW 4.91 trillion for the first half of 2026, while net income totaled KRW 2.80 trillion, according to management’s second-quarter earnings conference call.
First-half revenue rose 0.3% year over year to KRW 46.32
Advantage Solutions (NASDAQ:ADV) executives highlighted continued growth in its experiential and merchandising operations, while outlining plans to use stronger cash generation to reduce leverage and support investments in the business.
Speaking at a Canaccord event, Chief Executive Officer Dave Pe
Franco-Nevada (NYSE:FNV) reported higher second-quarter production-equivalent sales and record first-half financial results, aided by stronger precious-metal and oil prices, increased production at key assets, and contributions from recently acquired interests.
President and Chief Executive Officer
T1 Energy, formerly FREYR Battery (NYSE:FREY), reported higher solar-module production and improved gross margins in the second quarter of 2026 as it continued construction of its planned U.S. solar-cell factory in Rockdale, Texas.
Chairman and CEO Dan Barcelo said the company is pursuing its goal
Presidio Production (NYSE:FTW) reported second-quarter net income attributable to the company of $14.4 million, or $0.34 per Class A share, as adjusted EBITDA reached $33.2 million, exceeding the $30 million the company had previously discussed.
The oil and gas operator, which focuses on acquiring
Intercorp Financial Services (NYSE:IFS) reported second-quarter 2026 net income of PEN 585 million and return on equity of 18.5%, with management citing continued growth in higher-yielding loans, insurance premiums and wealth-management assets.
Chief Executive Officer Luis Felipe Castellanos said q
Brinker International (NYSE:EAT) reported fourth-quarter fiscal 2026 results marked by continued same-store sales growth at Chili’s, higher earnings and restaurant margin expansion, while management said it expects another year of sales and traffic gains in fiscal 2027.
Chili’s same-store sales inc
Central Puerto (NYSE:CEPU) reported second-quarter 2026 adjusted EBITDA of $145.0 million, up 20.1% from the first quarter and 136.2% from a year earlier, as higher contracted sales, seasonal spot-market pricing and margins from self-procured fuel lifted results.
Revenue totaled $453.3 million, ris
PodcastOne (NASDAQ:PODC) reported record fiscal first-quarter 2027 revenue of $16.1 million, while adjusted EBITDA increased to $1.6 million as the podcast network expanded its creator roster, advanced in audience rankings and emphasized video distribution and advertising opportunities.
The company
Nebius Group's Q2 revenue surged 454% year-over-year to over $582 million, driven by faster capacity ramps, with analysts bullish but price targets suggesting shares are fairly valued near $230.
Embraer posted a Q2 earnings beat, raised full-year EBIT margin and free cash flow guidance, and grew its backlog to $34.5 billion, gaining ground on Boeing and Airbus.
Borr Drilling (NYSE:BORR) reported lower second-quarter adjusted EBITDA and a wider net loss as rig transitions, startup costs for the Odin rig, higher fuel and insurance expenses, and a credit-loss provision weighed on results. Management said it expects a significant sequential improvement in the
Candel Therapeutics (NASDAQ:CADL) is advancing two off-the-shelf viral immunotherapy candidates designed for local administration intended to generate systemic immune responses against tumors, Chief Scientific Officer Francesca Barone said at the Canaccord Genuity Growth Conference in Boston.
The c
American Integrity Insurance Group (NYSE:AII) reported record second-quarter earnings and voluntary new-business production, as the Florida-focused property insurer expanded in key in-state markets and continued building its presence across the Southeast.
The company generated net income of $34.1 m
Amcor (NYSE:AMCR) reported fiscal 2026 fourth-quarter adjusted earnings per share of $1.23, up 23% from a year earlier, as synergy gains from its acquisition of Berry Global, cost management and modest volume growth supported results amid elevated input-cost inflation.
For the full fiscal year, adj
BETA Technologies (NYSE:BETA) reported second-quarter revenue of $14.7 million, exceeding its prior guidance range of $8 million to $11 million and representing 146% year-over-year growth. The company said results were driven primarily by revenue recognized from its Electrified Powertrain Flight Dem
Adecoagro (NYSE:AGRO) reported record consolidated adjusted EBITDA of $173 million for the second quarter and $258 million for the first half of 2026, led by its fertilizer business as higher production, pricing and operating efficiencies more than offset softer results in sugar, ethanol, energy, fo
Applied Aerospace & Defense (NYSE:AADX) reported record second-quarter revenue and adjusted EBITDA in its first earnings call as a public company, while highlighting a growing contract backlog, capacity investments and continued demand across space and defense programs.
Revenue for the second q
WeRide (NASDAQ:WRD) reported second-quarter 2026 revenue growth of 82% from a year earlier and 103% sequentially, as the autonomous-driving company cited overseas expansion, an asset-light Robotaxi model and the initial mass production of its L2+/L3 advanced driver-assistance systems.
Revenue total
WhiteFiber (NASDAQ:WYFI) reported second-quarter revenue growth and outlined progress across its North Carolina colocation campus, Canadian facilities and cloud services business, as management emphasized a strategy centered on contracted infrastructure, customer prepayments and project-level financ
Elemental Royalty (NASDAQ:ELE) reported its second-highest quarterly revenue result in company history for the second quarter of 2026, as the royalty company benefited from growth in its portfolio following its combination with EMX Royalty.
President and COO Frederick Bell said the company recorded
Intel upsized its stock offering to $20 billion on Aug. 11, bolstering its balance sheet for AI-era capital needs even as the raise dilutes existing shareholders amid its ongoing turnaround.
Visa benefits from AI-driven commerce growth without picking a winner, posting record $4 trillion quarterly payment volume as analysts raise price targets toward all-time highs.
Trimble (NASDAQ:TRMB) reported second-quarter results that exceeded its guidance midpoint, driven by strength in its architecture, engineering, construction and operations business and Field Systems segment. The company also raised its full-year outlook, authorized a new $1 billion share repurchase
Compass Pathways (NASDAQ:CMPS) said it remains on track to complete a new drug application for COMP360, its investigational psilocybin treatment for treatment-resistant depression, in the fourth quarter of this year, with a potential U.S. launch expected in the first half of 2027.
During Canaccord
Radcom (NASDAQ:RDCM) reported second-quarter revenue of $11.8 million, down 33.4% from $17.7 million a year earlier, as certain planned expansion deployments at a limited number of existing Tier 1 customers were delayed by rising server infrastructure costs.
Chief Executive Officer Benny Eppstein s
Stabilis Solutions (NASDAQ:SLNG) reported second-quarter 2026 revenue of $11.9 million, down approximately 31% from the prior-year period, as large marine and power-generation contracts concluded in late 2025. The company said growing aerospace and industrial activity partially offset the impact of
PolyPid (NASDAQ:PYPD) said its second-quarter 2026 was marked by the FDA’s acceptance of its new drug application for D-PLEX100 and a commercialization agreement with Azurity Pharmaceuticals covering the United States and Canada.
D-PLEX100 is being developed to prevent surgical site infections in p
Nexxen International (NASDAQ:NEXN) reported record second-quarter results for the period ended June 30, 2026, led by growth in connected television, mobile and data products, while raising its full-year outlook for contribution ex-TAC and programmatic revenue.
Chief Executive Officer Ofer Druker sa
LiveOne (NASDAQ:LVO) reported fiscal 2027 first-quarter consolidated revenue of $19.4 million and adjusted EBITDA of $4.3 million for the three months ended June 30, according to Interim CFO Craig Christensen. The company posted a GAAP net loss of $3.1 million, or $0.23 per basic and diluted share,
Fervo Energy (NASDAQ:FRVO) said it advanced 400 megawatts of capacity into advanced development during the second quarter, expanded its geothermal mineral-rights position to more than 650,000 acres and reiterated plans to begin initial generation at its Cape Station project in the fourth quarter of
On Holdings shares fell on a revenue miss tied to wholesale strategy and FX, but margins widened and earnings beat estimates, with analysts maintaining a Moderate Buy consensus.
Taiwan Semiconductor's monthly sales jumped 44.7%, signaling robust AI chip demand even as it raises 2025 capital spending guidance to $60 billion to $64 billion amid investor caution.
CeriBell (NASDAQ:CBLL) outlined its plans to expand its brainwave-monitoring platform beyond seizure detection, pointing to new products for delirium, pediatric patients and eventually stroke as it continues to build its hospital customer base.
Speaking at Canaccord’s 46th Annual Global Growth Conf
Milestone Pharmaceuticals (NASDAQ:MIST) reported early commercial traction for CARDAMYST following its mid-February launch, while advancing a pivotal Phase III study of etripamil in atrial fibrillation with rapid ventricular rate, or AFib-RVR.
Chief Executive Officer Joseph Oliveto said CARDAMYST r
Marex Group plc Ordinary Shares (NASDAQ:MRX) reported record second-quarter profit as revenue growth across its clearing, agency and execution, market-making and solutions businesses offset lower exchange volumes and declining market volatility from the first quarter.
Second-quarter revenue rose 39
Nebius Group (NASDAQ:NBIS) reported second-quarter 2026 revenue growth of 454% from a year earlier as its AI cloud business expanded capacity and utilization, while management reaffirmed its full-year outlook and outlined plans for additional capacity deployment in 2027.
Group revenue rose to $582
Gladstone Land (NASDAQ:LAND) reported a second-quarter net loss of approximately $8.5 million, while management pointed to improving almond and pistachio pricing, potential revenue from re-leasing vacant acreage, and plans to continue reviewing farms for possible sales.
Chief Executive Officer Davi
Liquidia (NASDAQ:LQDA) reported second-quarter 2026 results marked by continued growth for its inhaled treprostinil product YUTREPIA, increased profitability and expanding investment in its clinical pipeline.
Chief Executive Officer Roger Jeffs said the company had received approximately 5,900 uniq
Kornit Digital (NASDAQ:KRNT) reported second-quarter 2026 revenue above its guidance range, supported by growth in annual recurring revenue, all-inclusive click agreements and demand from traditional screen printers transitioning to digital production.
Revenue for the quarter totaled $55.3 million,
Kamada (NASDAQ:KMDA) reported record revenue and adjusted EBITDA for the second quarter and first half of 2026, driven by higher sales of its specialty plasma-derived products, including KEDRAB, VARIZIG and HEPAGAM. The company reiterated its full-year guidance and said it expects initial sales unde
CoreWeave shares rallied after Q2 revenue grew 113% year-over-year and its backlog topped $104 billion, though analysts remain cautious about cash burn, debt, and the path to profitability.
Tesla's thin auto margins and negative free cash flow are pressuring its stock as investors await Robotaxi deployment data to justify its 300x earnings multiple.
Chipmos Technologies (NASDAQ:IMOS) reported second-quarter revenue at its highest level since 2014, with stronger pricing, product mix and factory utilization lifting profitability as demand continued to exceed available capacity, Chairman and President S.J. Cheng said on the company’s 2026 semi-ann
Ituran Location and Control (NASDAQ:ITRN) reported record second-quarter revenue and profitability for 2026, driven by growth in recurring subscription revenue, subscriber additions and expanding original equipment manufacturer relationships.
Revenue for the quarter rose 21% year over year to $104.
BioMarin Pharmaceutical (NASDAQ:BMRN) outlined its growth strategy, integration plans for Amicus Therapeutics and pipeline priorities during a Canaccord discussion with Chief Financial Officer Brian Mueller.
Mueller described BioMarin as one of the largest rare-disease-focused biopharmaceutical com
Eastern (NASDAQ:EML) reported lower second-quarter sales and adjusted earnings from continuing operations, while management pointed to a sharply higher backlog, improving heavy-truck demand and its newly acquired aerospace and defense businesses as support for a stronger second half of fiscal 2026.
National Vision (NASDAQ:EYE) reported second-quarter 2026 revenue growth and improved profitability as higher average ticket sales and premium product attachment offset lower customer traffic, including temporary disruption from an e-commerce platform transition.
Net revenue rose 2.5% to $499 milli
Global-e Online (NASDAQ:GLBE) reported second-quarter 2026 results that exceeded its prior guidance ranges, citing strong same-store sales, merchant launches and promotional activity. The company raised its full-year outlook for gross merchandise value, revenue and adjusted EBITDA and included expec
Anterix (NASDAQ:ATEX) said it is seeing accelerating interest in its licensed low-band spectrum portfolio as demand grows among utilities, wireless providers and satellite connectivity companies. The company also reported first-quarter fiscal 2027 revenue of $2 million, an approximately $11 million
Altimmune (NASDAQ:ALT) said it has initiated patient enrollment in its global Phase III PERFORMA trial of pemvidutide for metabolic dysfunction-associated steatohepatitis, or MASH, while advancing plans for later-stage development in alcohol use disorder, or AUD.
Chairman and Chief Executive Office
Aquestive Therapeutics (NASDAQ:AQST) said it plans to resubmit its new drug application for Anaphylm, its epinephrine sublingual film candidate for type 1 allergic reactions including anaphylaxis, before the end of the third quarter after completing studies requested by the U.S. Food and Drug Admini
Bilfinger (ETR:GBF) reported higher second-quarter revenue and earnings per share while citing delays in customer spending and temporary underutilization related to market uncertainty. The industrial services company confirmed its 2026 outlook, though it said it now expects to land at the lower end
Hims & Hers topped Q2 revenue estimates and raised guidance, but missed EPS forecasts, posted a wider net loss, and faces an FTC lawsuit, leaving Wall Street cautious with a Hold rating.
Cameco-backed Westinghouse Electric has filed confidentially for a potential IPO, a move that could ease Cameco's debt load and boost investor interest in nuclear stocks like NuScale Power and Fluor.
ASP Isotopes (NASDAQ:ASPI) outlined plans to expand its isotope production, radiopharmacy and helium businesses during Canaccord Genuity’s 46th Annual Growth Conference, with commercial deliveries of several stable isotopes targeted for the second half of 2026.
Chief Commercial Officer Viktor Petko
Annexon (NASDAQ:ANNX) said it expanded its pivotal ARCHER II trial of vonaprument in geographic atrophy, adding an independent 24-month dual primary endpoint alongside the study’s existing 15-month primary endpoint. The company said it remains confident in a planned fourth-quarter assessment of the
Humacyte (NASDAQ:HUMA) reported second-quarter commercial sales growth while outlining plans to expand adoption of its SYMVESS vascular repair product, submit a supplemental biologics license application for dialysis access and begin a first-in-human coronary bypass study.
Commercial sales totaled
Boyd Group Services (TSE:BYD) reported second-quarter 2026 revenue above $1 billion for the first time, as the company expanded its footprint, integrated Joe Hudson’s Collision Center and advanced its Project 360 cost-transformation program.
Revenue rose 30% year over year to $1.013 billion, while
Acumen Pharmaceuticals (NASDAQ:ABOS) said it remains on track to report top-line results late in 2026 from its Phase II ALTITUDE-AD study of sabirnetug, an investigational antibody designed to selectively target synaptotoxic amyloid-beta oligomers in early Alzheimer’s disease.
Chief Executive Offic
Fastly shares jumped 27% after strong Q2 revenue and margin growth prompted analyst price target hikes and heavy institutional buying, though its high valuation remains a key risk.
Cardiol Therapeutics (NASDAQ:CRDL) is advancing its synthetic, pharmaceutical-grade cannabidiol formulation, CardiolRx, in a pivotal Phase III trial for recurrent pericarditis, with management describing the program as a key step toward a potential new drug application.
Speaking at a Canaccord Genu
Paramount Skydance's 30-film theatrical guarantee could stabilize cinema chains like AMC, but the plan hinges on its Warner Bros. Discovery merger surviving a March 2027 antitrust trial.
Coincheck Group (NASDAQ:CNCK) is positioning its business around institutional crypto infrastructure, execution and asset management as regulatory developments in Japan and other markets broaden access to digital assets, Chief Executive Officer Pascal St-Jean said during a KeyBanc discussion.
St-Je
Hill & Smith (LON:HILS) reported a strong first-half performance for 2026, led by double-digit growth in its U.S. operations and prompting the group to raise its full-year operating profit expectations.
Revenue reached $607 million, up 5% on an organic constant-currency basis, while underlying oper
Clene (NASDAQ:CLNN) said it is preparing to submit a new drug application, or NDA, in early fourth quarter for CNM-Au8 as a potential treatment for amyotrophic lateral sclerosis, following a series of meetings with the U.S. Food and Drug Administration.
President and CEO Rob Etherington said the co
Balfour Beatty (LON:BBY) reported higher first-half revenue, profit and cash generation for 2026, citing growth in U.S. buildings and U.K. power transmission as well as an improved performance in U.S. construction.
Group Chief Executive Philip Hoare said the company delivered “profitable growth and
Jenoptik (ETR:JEN) reported a return to revenue growth and a sharp improvement in profitability in the first half of 2026, supported by demand in its semiconductor-focused operations and strong order activity in Biophotonics. The company also raised the specificity of its full-year outlook, forecast
C.H. Robinson Worldwide (NASDAQ:CHRW) executives said the company plans to appeal a large jury verdict tied to a fatal accident in Dallas, while maintaining that the outcome will not alter its operating strategy, capital allocation priorities or outlook for its brokerage business.
Speaking at the C
K+S Aktiengesellschaft (ETR:SDF) raised its full-year 2026 outlook after second-quarter EBITDA rose significantly from the prior-year period, supported by higher average selling prices, stronger volumes and cost discipline.
CEO Christian H. Meyer said second-quarter EBITDA reached approximately €17
CLS (LON:CLI) reported lower first-half earnings as property disposals, tenant departures and valuation declines weighed on results, while the office investor continued its program of asset sales, debt reduction and refinancing.
Chief Executive Fredrik Widlund said the company faces “near-term earn
Evoke (LON:EVOK) reported stable first-half revenue and lower adjusted EBITDA as increased gaming duties, particularly in the U.K., added a £46 million year-on-year cost headwind. Management said mitigation efforts, including more efficient marketing, cost savings and retail estate changes, offset m
